That is the question a new paper by Chambers et al. (2025) aims to answer. The authors use data from the Specialty Drug Evidence and Coverage (SPEC) Database, which contains coverage policies related to specialty pharmacy for a large number of US health plans, to examine how n=25 cell and gene therapies are being covered…
AI continues to dominate digital health funding, but investors and health systems are demanding proof that these tools actually save money — and quickly. AI startups without clear, measurable ROI are finding it harder to stand out, explained Vig Chandramouli, partner at Oak HC/FT. The post Why ‘Time-to-Value’ Is the #1 Metric Healthcare AI Customers…
Financial and policy trends are shifting the M&A landscape now, says a Kaufman Hall expert
UnitedHealthcare has partnered with Aeroflow Health to provide virtual, dietitian-led nutrition services for members managing chronic conditions. The post UHC Taps Aeroflow Health for Virtual Nutrition Services appeared first on MedCity News.
Increasing costs are driven by chronic diseases, pharmacy expenses, and labor shortages
Collaborative for Healthy Rural America includes Lumeris, Teladoc Health, Nuna, Deloitte, and Unite Us
The FDA has approved UCB’s Kygevvi for treating children and adults with thymidine kinase 2 deficiency, an inherited mitochondrial disorder. It’s the drugmaker’s first ultra-rare disease product. The post UCB Drug Becomes First FDA-Approved Treatment for Ultra-Rare and Fatal Mitochondrial Disease appeared first on MedCity News.
Genomic technologies not only help to identify cancers, but also offer opportunities for assessing the potential efficacy of different treatment options. By analyzing the genomic profile of a particular patient, doctors can see which medications might offer the most support, and which could cause more harm. The post Oncologists Turn To Genomics For Improved Answers…
Many of today’s systems weren’t built for speed, supervision, or scale, and they can’t support the level of intelligence or flexibility that modern care delivery demands. The solution isn’t to retreat from APPs. It’s to invest in models that make their work safe, effective, and scalable. The post The Future of Specialty Care: APPs, MDs,…
Economist Vivian Ho has been researching the U.S. health care system for four decades. These days, she’s focused on what she thinks are the biggest burdens on the average American: runaway hospital prices and rising health insurance premiums. She has developed a strategy for addressing high insurance premiums — one that’s based on giving patients…